Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin D Berger

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
BMJ Case Reports|August 30, 2024
Non-specific presentation of metastatic small bowel adenocarcinoma with diagnostic challengesDora Chakroun, Nathalie Marnas, Ioannis Kapoglou, et al.
Annals of Diagnostic Pathology|April 3, 2012
Mucin-producing adenocarcinoma arising in an atrial myxomaMartin D Berger, Jakob Schneider, Peter E Ballmer, et al.
Hematological Oncology|November 23, 2019
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemiaAlexander D Heini, Rebecca Hugo, Martin D Berger, et al.
Hematological Oncology|June 16, 2016
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemiaMartin D Berger, Alexander D Heini, Katja Seipel, et al.
BJS Open|January 7, 2026
Effect of hospital volume on gastric cancer resection outcome in Switzerland: 24-year nationwide retrospective analysisJoël L Gerber, Martin Müller, Martin D Berger, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Predictors and Patterns of Recurrence After a Watchful Waiting Approach following Clinical Complete Response to Neoadjuvant Radiochemotherapy for Esophageal CancerSarah Gerber, Martin D Berger, Hossein Hemmatazad, et al.
BMC Cancer|March 25, 2026
Effect of healthcare professional-delivered health literacy interventions on patient reported outcomes in cancer patients - a systematic reviewMalui Katrischa Frei, Gieri Cathomas, Monica Fliedner, et al.
NPJ Precision Oncology|August 13, 2024
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibitionHannah L Williams, Ana Leni Frei, Thibaud Koessler, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2020
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patientsInti Zlobec, Heather E Dawson, Annika Blank, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
BMJ Case Reports|August 30, 2024
Non-specific presentation of metastatic small bowel adenocarcinoma with diagnostic challengesDora Chakroun, Nathalie Marnas, Ioannis Kapoglou, et al.
Annals of Diagnostic Pathology|April 3, 2012
Mucin-producing adenocarcinoma arising in an atrial myxomaMartin D Berger, Jakob Schneider, Peter E Ballmer, et al.
Hematological Oncology|November 23, 2019
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemiaAlexander D Heini, Rebecca Hugo, Martin D Berger, et al.
Hematological Oncology|June 16, 2016
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemiaMartin D Berger, Alexander D Heini, Katja Seipel, et al.
BJS Open|January 7, 2026
Effect of hospital volume on gastric cancer resection outcome in Switzerland: 24-year nationwide retrospective analysisJoël L Gerber, Martin Müller, Martin D Berger, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Predictors and Patterns of Recurrence After a Watchful Waiting Approach following Clinical Complete Response to Neoadjuvant Radiochemotherapy for Esophageal CancerSarah Gerber, Martin D Berger, Hossein Hemmatazad, et al.
BMC Cancer|March 25, 2026
Effect of healthcare professional-delivered health literacy interventions on patient reported outcomes in cancer patients - a systematic reviewMalui Katrischa Frei, Gieri Cathomas, Monica Fliedner, et al.
NPJ Precision Oncology|August 13, 2024
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibitionHannah L Williams, Ana Leni Frei, Thibaud Koessler, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2020
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patientsInti Zlobec, Heather E Dawson, Annika Blank, et al.
Pageof 12